1. Home
  2. Stocks
  3. Hcg Share Price

Healthcare Global Enterprises Share Price

Healthcare Mid Cap

₹474.65 +27.75 (6.21%)

05 Nov, 2024 16:51

SIP TrendupStart SIP in HCG

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹443
  • High
  • ₹520
  • 52 Week Low
  • ₹314
  • 52 Week High
  • ₹520
  • Open Price₹443
  • Previous Close₹447
  • Volume1,178,926

Investment Returns

  • Over 1 Month + 10.37%
  • Over 3 Month + 30.85%
  • Over 6 Month + 28.51%
  • Over 1 Year + 26.49%
SIP Lightning

Smart Investing Starts Here Start SIP with Healthcare Global Enterprises for Steady Growth!

Healthcare Global Enterprises Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 125.7
  • PEG Ratio
  • 1.8
  • Market Cap Cr
  • 6,614
  • P/B Ratio
  • 7.6
  • Average True Range
  • 16.14
  • EPS
  • 3
  • Dividend Yield
  • 0
  • MACD Signal
  • 6.82
  • RSI
  • 58.27
  • MFI
  • 45.46

Healthcare Global Enterprises Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations293.61280.38267.21282.75272.23
Total Income From Operations293.61280.38267.21282.75272.23
P/L Before Interest, Excpt. Items & Tax34.5533.7828.1629.2627.73
P/L Before Exceptional Items & Tax15.2119.6914.9518.2818.04
P/L After Tax from Ordinary Activities11.72-1.768.3313.7013.69
Net Profit/Loss For the Period11.72-1.768.3313.7013.69
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,102.57996.16
Revenue From Operations [Net]1,102.57996.16
Total Operating Revenues1,102.571,005.57
Total Revenue1,116.171,016.39
Total Expenses1,045.21955.77
Profit/Loss Before Tax54.8657.62
Profit/Loss For The Period33.9640.19
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity194.73130.40
Net Cash Used In Investing Activity-249.22-137.70
Net Cash Used in Finance Activity105.36-41.71
Net Inc/Dec In Cash And Equivalent50.87-49.02
Cash And Equivalent End Of Year222.6070.31
IndicatorMar 24Mar 23
Total Share Capital139.29139.12
Total Non-Current Liabilities625.87363.79
Total Current Liabilities373.43220.80
Total Capital And Liabilities2,187.891,729.71
Total Non-Current Assets1,674.821,357.19
Total Current Assets513.07372.52
Total Assets2,187.891,729.71
Indicator20242023
EBIT Margin (%)10.7810.15
Return On Capital Employed (%)6.556.76
Return On Equity (%)2.853.50
Long Term Debt To Equity (%)21.919.84
Book Value/Share (INR)85.3382.31
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations525.58494.63469.87486.94460.68
Total Income From Operations525.58494.63469.87486.94460.68
P/L Before Interest, Excpt. Items & Tax52.7151.1040.5344.8235.72
P/L Before Exceptional Items & Tax19.0024.2611.0717.9310.17
P/L After Tax from Ordinary Activities13.6423.403.4410.793.30
Net Profit/Loss For the Period13.6423.403.4410.793.30
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,912.121,676.05
Revenue From Operations [Net]1,912.121,676.05
Total Operating Revenues1,912.121,691.41
Total Revenue1,929.061,707.63
Total Expenses1,865.631,662.73
Profit/Loss Before Tax67.3344.90
Profit/Loss For The Period40.9317.65
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity284.58251.59
Net Cash Used In Investing Activity-225.73-133.03
Net Cash Used in Finance Activity-64.02-140.07
Net Inc/Dec In Cash And Equivalent-5.17-21.51
Cash And Equivalent End Of Year272.61171.18
IndicatorMar 24Mar 23
Total Share Capital139.29139.12
Total Non-Current Liabilities1,098.68876.28
Total Current Liabilities743.70570.32
Total Capital And Liabilities2,707.502,316.02
Total Non-Current Assets2,027.651,735.68
Total Current Assets679.85580.34
Total Assets2,707.502,316.02
Indicator20242023
EBIT Margin (%)9.008.77
Return On Capital Employed (%)8.768.50
Return On Equity (%)5.823.41
Long Term Debt To Equity (%)58.7642.03
Book Value/Share (INR)62.1162.50

Healthcare Global Enterprises Technicals

EMA & SMA

Current Price
₹474.65
+ 27.75 (6.21%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹437.29
  • 50 Day
  • ₹421.30
  • 100 Day
  • ₹402.97
  • 200 Day
  • ₹383.60

Resistance and Support

446.38 Pivot Speed
  • R3 464.27
  • R2 458.13
  • R1 452.52
  • S1 440.77
  • S2 434.63
  • S3 429.02

Is Healthcare Global Enterprises Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Healthcare Global Enterprises Ltd. (HCG) is India’s largest provider of cancer care, operating a network of specialized hospitals across the country. It offers advanced oncology treatments, including radiation, chemotherapy, and surgical oncology, focusing on personalized patient care. Healthcare Global Ents. has an operating revenue of Rs. 1,977.02 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 4% needs improvement, ROE of 5% is fair but needs improvement. The company has a debt to equity of 59%, which is bit higher. The stock from a technical standpoint is comfortably placed above its key moving averages, around 7% and 19% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Healthcare Global Enterprises Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-09 Quarterly Results
2024-08-08 Quarterly Results
2024-05-29 Audited Results & ESOP
2024-02-08 Quarterly Results
2023-11-09 Quarterly Results

Healthcare Global Enterprises F&O

Healthcare Global Enterprises Shareholding Pattern

71.23%
8.94%
0.19%
4.3%
9.34%
6%
  • NSE Symbol
  • HCG
  • BSE Symbol
  • 539787
  • ISIN
  • INE075I01017

Healthcare Global Enterprises FAQs

Healthcare Global Enterprises share price is ₹474 As on 05 November, 2024 | 16:37

The Market Cap of Healthcare Global Enterprises is ₹6614.1 Cr As on 05 November, 2024 | 16:37

The P/E ratio of Healthcare Global Enterprises is 125.7 As on 05 November, 2024 | 16:37

The PB ratio of Healthcare Global Enterprises is 7.6 As on 05 November, 2024 | 16:37

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.